Related by context. Frequent words. (Click for all words.) 75 phase IIa clinical 73 phase IIb clinical 73 phase IIa 72 Phase Ib clinical 72 Pivotal Phase III 72 Phase 1b clinical 70 Initiate Phase 70 Panzem R 69 MKC# 68 refractory chronic lymphocytic 68 forodesine 68 Phase IIb trials 68 Phase IIa clinical 68 Pirfenidone 68 Pivotal Trial 68 Phase 2a clinical 68 phase IIb 68 INCB# [001] 68 diabetic neuropathic pain 67 Phase III Clinical Trial 67 R sorafenib tablets 67 confirmatory Phase III 67 Phase Ib 67 Phase 2b clinical 67 Phase IIb clinical 67 Phase 1b trial 67 Pivotal Phase 67 Phase IIIb 67 Phase 2b clinical trials 66 Phase IIa trial 66 Belimumab 66 Presents Positive 66 placebo controlled clinical 66 GLPG# 66 Phase III Trial 66 Ixempra 65 NVA# 65 Patient Enrollment 65 SAR# [004] 65 phase 2a 65 Ofatumumab 65 multicenter Phase 65 GVAX R 65 Clinical Trial Results 65 confirmatory Phase 3 65 Completes Enrollment 65 Diabetic Macular Edema 65 relapsed multiple myeloma 65 elotuzumab 65 registrational trial 65 Nexavar ® 64 pivotal Phase III 64 relapsed refractory multiple myeloma 64 IIa trial 64 Alemtuzumab 64 Hepatitis C HCV 64 metastatic hormone refractory 64 deforolimus 64 Tesetaxel 64 Diamyd R 64 IMC #B 64 StemEx 64 relapsing multiple sclerosis 64 Laquinimod 64 INTERCEPT red 64 Mipomersen 64 Bicifadine 64 metastatic castration resistant 64 subcutaneous formulation 64 KRN# 64 Phase 1b 64 Allovectin 7 R 64 Cetrorelix 64 Randomized controlled 63 Pulmonary Arterial Hypertension 63 Phase Ia 63 ZALBIN 63 Phase III clinical 63 blinded placebo controlled 63 Fibrillex TM 63 Cloretazine R VNP#M 63 Diamyd ® 63 placebo controlled Phase 63 Phase IIa 63 Traficet EN 63 Phase III randomized 63 registrational 63 Amrubicin 63 OncoVEX GM CSF 63 pseudobulbar affect PBA 63 DDP# 63 Bavituximab 63 label multicenter 63 Entereg R 63 Elesclomol 63 PEG SN# 63 ganetespib 62 Phase 1a 62 Phase 2a trial 62 FDA Accepts 62 mRCC